市場調查報告書

過敏性氣喘治療藥的全球市場 - 各藥物類型·各給藥途徑·各地區:市場規模·佔有率·未來展望·機會分析

Allergic Asthma Therapeutics Market, by Drug Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 952844
出版日期 內容資訊 英文 170 Pages
商品交期: 2-3個工作天內
價格
過敏性氣喘治療藥的全球市場 - 各藥物類型·各給藥途徑·各地區:市場規模·佔有率·未來展望·機會分析 Allergic Asthma Therapeutics Market, by Drug Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月22日內容資訊: 英文 170 Pages
簡介

本報告提供全球過敏性氣喘的治療藥的市場相關分析,提供疾病·產品概要,及市場基本結構及促進·阻礙因素,整體市場規模預測 (以金額為準,過去3年·今後8年份),醫各類型藥品·各給藥途徑·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃等調查。

目錄

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 過敏性氣喘治療的技術進步
  • 近幾年主要的動向
  • 企業收購,事業合作·聯盟
  • 流行病學
  • 開發平台分析
  • 專利的有效期限
  • 價格分析

第4章 全球過敏性氣喘治療藥市場,新型冠狀病毒感染疾病 (COVID-19)的影響

  • "COVID-19前" 狀況
  • "COVID-19後" 的需求
  • 過敏性氣喘治療的必要性
  • 各監管機構的建議和指南

第5章 全球過敏性氣喘治療藥市場:各藥物類型

  • 簡介
  • 支氣管擴張藥
  • 皮質類固醇
  • 生技藥品
  • 白三烯修飾藥
  • 免疫療法
  • 其他

第6章 全球過敏性氣喘治療藥市場:各給藥途徑

  • 簡介
  • 口服藥
  • 吸入藥
  • 其他

第7章 全球過敏性氣喘治療藥市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第8章 競爭情形

  • 企業簡介
    • Aslan Pharmaceuticals Pte. Ltd.
    • Baxalta Incorporated
    • Axikin Pharmaceuticals
    • Chiesi Farmaceutici SpA
    • CSL Limited
    • Circassia Pharmaceuticals Plc
    • Fountain Biopharma Inc.
    • Hydra Biosciences
    • GlaxoSmithKline Plc
    • Infinity Pharmaceuticals
    • Mabtech Limited
    • Kineta
    • Marinomed Biotechnologie GmbH
    • NeoPharm Co.
    • Mycenax Biotech Inc.
    • Panacea Biotec Limited
    • Oxagen Limited

第9章 附錄

目錄

Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Allergic asthma is one of the most common types of asthma. Allergic asthma is triggered by inhaling allergens such as mold, pollen, pet dander, and dust mite allergen resulting in symptoms of allergic asthma which include chest tightness, rapid breathing or shortness of breath, wheezing, and coughing.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the allergic asthma therapeutics market growth in future. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. According to the World Health Organization (WHO), more than 200 million people suffer from COPD and around 235 million have asthma all across the globe.

Allergic asthma therapeutics are cost-effective and gaining popularity among patients and healthcare professionals due to launches of novel drugs by key players. This is estimated to drive the market growth during the forecast period.

Moreover, governments are taking initiatives to provide better care and treatment for patients, and are focusing on increasing awareness about allergic asthma which is contributing to the allergic asthma therapeutics market growth. However, the increasing use of generic drugs and upsurge in patent expiry of drugs are predicted to restrict the market growth in the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global allergic asthma therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global allergic asthma therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited.
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global allergic asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for allergic asthma therapeutics market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Allergic Asthma Therapeutics Market, By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
  • Global Allergic Asthma Therapeutics Market, By Route of Administration:
    • Oral
    • Inhaled
    • Others
  • Global Allergic Asthma Therapeutics Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
      • By Route of Administration:
    • Oral
    • Inhaled
    • Others
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
      • By Route of Administration:
    • Oral
    • Inhaled
    • Others
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
      • By Route of Administration:
    • Oral
    • Inhaled
    • Others
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
      • Others By Route of Administration:
    • Oral
    • Inhaled
    • Others
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
      • By Route of Administration:
    • Oral
    • Inhaled
    • Others
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
      • Others By Route of Administration:
    • Oral
    • Inhaled
    • Others
  • Company Profiles
    • Aslan Pharmaceuticals, Pte. Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Baxalta Incorporated
    • Axikin Pharmaceuticals
    • Chiesi Farmaceutici SpA
    • CSL Limited
    • Circassia Pharmaceuticals Plc
    • Fountain Biopharma Inc.
    • Hydra Biosciences
    • GlaxoSmithKline Plc
    • Infinity Pharmaceuticals
    • Mabtech Limited
    • Kineta
    • Marinomed Biotechnologie Gmb
    • NeoPharm Co.
    • Mycenax Biotech Inc.
    • Panacea Biotec Limited
    • Oxagen Limited

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements in Allergic Asthma Therapeutics
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology
  • Pipeline Analysis
  • Patent Expiration
  • Pricing Analysis

4. Global Allergic Asthma Therapeutics Market, Impact of Coronavirus (Covid-19) Pandemic

  • Pre-COVID situation
  • Post-COVID demand
  • Need for Allergic Asthma Therapeutics
  • Recommendations and guidelines by regulatory bodies

5. Global Allergic Asthma Therapeutics Market, By Drug Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Bronchodilators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukotriene modifiers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Inhaled
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Allergic Asthma Therapeutics Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027(%)
    • Y-o-Y Growth Analysis, By Region, 2017 -2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Route of Administration, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Aslan Pharmaceuticals Pte. Ltd.
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Baxalta Incorporated
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Axikin Pharmaceuticals
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Chiesi Farmaceutici SpA
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CSL Limited
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Circassia Pharmaceuticals Plc
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fountain Biopharma Inc.
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hydra Biosciences
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline Plc
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Infinity Pharmaceuticals
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mabtech Limited
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Kineta
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Marinomed Biotechnologie GmbH
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • NeoPharm Co.
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mycenax Biotech Inc.
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Panacea Biotec Limited
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Oxagen Limited
    • Company Overview
    • Type Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact